Plasma platelet-derived microparticles in patients with connective tissue diseases

Journal of Rheumatology

Volumn 38, Issue 4, 2011, Pages 680-684

  Oyabu, Chinami ^a   Morinobu, Akio ^a   Sugiyama, Daisuke ^a   Saegusa, Jun ^a   Tanaka, Shino ^a   Morinobu, Sahoko ^a   Tsuji, Goh ^a   Kasagi, Shimpei ^a   Kawano, Seiji ^b   Kumagai, Shunichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Connective tissue diseases; Microparticle; Platelet; Raynaud's phenomenon

Indexed keywords

ACETYLSALICYLIC ACID; BERAPROST; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; ICOSAPENTAENOIC ACID ETHYL ESTER; KALLIGINOGENASE; LIMAPROST; PREDNISOLONE; SARPOGRELATE; TICLOPIDINE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CONNECTIVE TISSUE DISEASES; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 79953332135     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100780     Document Type: Article

References (24)

1. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 2005;52:3337-48. (Pubitemid 41612200)
2. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007;21:157-71. (Pubitemid 46529055)
3. Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008;123:8-23.
4. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009;101:439-51.
5. George FD. Microparticles in vascular diseases. Thromb Res 2008;122 Suppl 1:S55-9.
6. Michelsen AE, Noto AT, Brodin E, Mathiesen EB, Brosstad F, Hansen JB. Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state. Thromb Res 2009;123:881-6.
7. Nauta AJ, Trouw LA, Daha MR, Tijsma O, Nieuwland R, Schwaeble WJ, et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 2002;32:1726-36. (Pubitemid 34679160)
8. Distler JH, Huber LC, Hueber AJ, Reich CF 3rd, Gay S, Distler O, et al. The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis 2005;10:731-41. (Pubitemid 41187073)
9. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010;327:580-3.
10. Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS. New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 2004;53:210-30. (Pubitemid 40139594)
11. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002;46:1498-503. (Pubitemid 34620195)
12. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001;115:451-9. (Pubitemid 34203516)
13. Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 2008;58:2845-53.
14. Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 2010;6:21-9.
15. Osumi K, Ozeki Y, Saito S, Nagamura Y, Ito H, Kimura Y, et al. Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 2001;85:326-30. (Pubitemid 32140580)
16. Ozeki Y, Nomura S. Assay methods for platelet-derived microparticle - merit and problem. J Thromb Haemost 2004;15:286-92.
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
18. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
19. Kasukawa R, Tojo T, Miyawaki T. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp G, editors. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier; 1987:41-7.
20. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
21. Nomura S, Inami N, Ozaki Y, Kagawa H, Fukuhara S. Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia. Platelets 2008;19:192-8. (Pubitemid 351574449)
22. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology 2005;44:587-96. (Pubitemid 41487226)
23. Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004;43:428-33. (Pubitemid 38174150)
24. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004;286:H1910-5.